111 related articles for article (PubMed ID: 35025128)
21. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
22. [Retrospective analysis of risk factors of liver cirrhosis combined with overt hepatic encephalopathy: a single -center case-control study].
Fan YN; Ji TT; Liang RY; Yu YY; Xu JH
Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):133-136. PubMed ID: 33685081
[No Abstract] [Full Text] [Related]
23. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
[TBL] [Abstract][Full Text] [Related]
24. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
[TBL] [Abstract][Full Text] [Related]
25. Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites.
Kim SU; Han KH; Nam CM; Park JY; Kim DY; Chon CY; Ahn SH
J Gastroenterol Hepatol; 2008 Nov; 23(11):1722-7. PubMed ID: 18717757
[TBL] [Abstract][Full Text] [Related]
26. Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir).
Bourcier V; Winnock M; Ait Ahmed M; Sogni P; Pambrun E; Poizot-Martin I; Chaffaut C; Chevret S; Trinchet JC; Salmon D; ;
Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):214-21. PubMed ID: 22189509
[TBL] [Abstract][Full Text] [Related]
27. Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR.
D'Ambrosio R; Degasperi E; Anolli MP; Fanetti I; Borghi M; Soffredini R; Iavarone M; Tosetti G; Perbellini R; Sangiovanni A; Sypsa V; Lampertico P
J Hepatol; 2022 Feb; 76(2):302-310. PubMed ID: 34592366
[TBL] [Abstract][Full Text] [Related]
28. TIPS for management of portal-hypertension-related complications in patients with cirrhosis.
Allaire M; Walter A; Sutter O; Nahon P; Ganne-Carrié N; Amathieu R; Nault JC
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):249-263. PubMed ID: 31662286
[TBL] [Abstract][Full Text] [Related]
29. Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
Nahon P; Bourcier V; Layese R; Audureau E; Cagnot C; Marcellin P; Guyader D; Fontaine H; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Leroy V; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Dharancy S; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Benhamou Y; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Zucman D; Di Martino V; Thibaut V; Salmon D; Ziol M; Sutton A; Pol S; Roudot-Thoraval F;
Gastroenterology; 2017 Jan; 152(1):142-156.e2. PubMed ID: 27641509
[TBL] [Abstract][Full Text] [Related]
30. Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension.
Raeven P; Baron-Stefaniak J; Simbrunner B; Stadlmann A; Schwabl P; Scheiner B; Schaden E; Eigenbauer E; Quehenberger P; Mandorfer M; Baron DM; Reiberger T
Hepatol Int; 2020 Dec; 14(6):1083-1092. PubMed ID: 33000389
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of hepatic vein waveform by Doppler ultrasonography in cirrhotic patients with portal hypertension.
Ohta M; Hashizume M; Kawanaka H; Akazawa K; Tomikawa M; Higashi H; Kishihara F; Tanoue K; Sugimachi K
Am J Gastroenterol; 1995 Oct; 90(10):1853-7. PubMed ID: 7572908
[TBL] [Abstract][Full Text] [Related]
32. The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study.
Chen Z; Ran T; Cao H; Xu F; Zhou ZH; He S
Front Med (Lausanne); 2021; 8():685944. PubMed ID: 34262917
[No Abstract] [Full Text] [Related]
33. The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding.
Benedeto-Stojanov D; Nagorni A; Bjelaković G; Stojanov D; Mladenović B; Djenić N
Vojnosanit Pregl; 2009 Sep; 66(9):724-8. PubMed ID: 19877551
[TBL] [Abstract][Full Text] [Related]
34. Safety of variceal band ligation in patients with cirrhosis and portal vein thrombosis treated with anticoagulant therapy: A retrospective study.
Ponthus S; Spahr L; Casini A; Berney T; Frossard JL; Majno P; Elkrief L
Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):395-400. PubMed ID: 31464780
[TBL] [Abstract][Full Text] [Related]
35. [Preliminary application of transjugular intrahepatic portosystemic shunt in individualized treatment of patients with cirrhotic portal hypertension complicated with refractory ascites and variceal hemorrhage].
Jiang MM; Xu H; Zhang QQ; Wei N; Xu W; Cui YF; Liu HT; Zu MH; Wang WL; Gao ZK
Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(47):3737-3740. PubMed ID: 31874500
[No Abstract] [Full Text] [Related]
36. Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis.
Wiegand J; Kühne M; Pradat P; Mössner J; Trepo C; Tillmann HL
Aliment Pharmacol Ther; 2012 Jun; 35(12):1443-50. PubMed ID: 22530565
[TBL] [Abstract][Full Text] [Related]
37. Effects of surgical procedures on the occurrence and development of postoperative portal vein thrombosis in patients with cirrhosis complicated by portal hypertension.
Sun L; Zhou H; Gu L; Jiang C; Liu Y; Xu Q
Int J Surg; 2015 Apr; 16(Pt A):31-35. PubMed ID: 25701619
[TBL] [Abstract][Full Text] [Related]
38. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
Lv Y; Qi X; He C; Wang Z; Yin Z; Niu J; Guo W; Bai W; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Liu H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Xia J; Cai H; Yang Z; Wu K; Fan D; Han G;
Gut; 2018 Dec; 67(12):2156-2168. PubMed ID: 28970291
[TBL] [Abstract][Full Text] [Related]
39. A non-invasive method for evaluating cirrhotic portal hypertension by administration of 99mTc-MIBI per rectum.
Wang JY; Chen SL; Chen FZ; Xu WG; Hu DC; Chen XF; Jin G; Liu HY
J Gastroenterol Hepatol; 1995; 10(2):169-73. PubMed ID: 7787163
[TBL] [Abstract][Full Text] [Related]
40. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
Bosch J; Iwakiri Y
Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
